XML 82 R62.htm IDEA: XBRL DOCUMENT v3.25.3
License Agreements - Hangzhou Highlightll Pharmaceutical Agreement (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
License and other agreements          
Development milestone payment to be paid $ 155,538,000     $ 155,538,000  
Milestone payment to be paid upon regulatory achievement 701,975,000     701,975,000  
Commercial milestone payment to be paid 3,185,450,000     3,185,450,000  
Research and development 141,169,000   $ 157,607,000 513,120,000 $ 628,398,000
Highlightll Pharmaceutical Co, Ltd.          
License and other agreements          
Research and development 0 $ 15,000,000 $ 0   $ 0
Highlightll Pharmaceutical Co, Ltd. | Collaborative arrangement          
License and other agreements          
Development milestone payment to be paid 60,000,000     60,000,000  
Milestone payment to be paid upon regulatory achievement 37,500,000     37,500,000  
Commercial milestone payment to be paid $ 837,500,000     $ 837,500,000